Cryosite Limited (ASX:CTE)


right-arrow Created with Sketch. 0 (0%)
MCAP $22.45M
Last trade 16.14pm 18/01/2022 20mins delayed

Latest Announcements

11/01/2022CTECryosite Limited
08/12/2021CTECryosite Limited
08/12/2021 Price SensitivePSCTECryosite Limited
19/11/2021CTECryosite Limited
19/11/2021CTECryosite Limited
04/11/2021CTECryosite Limited
15/10/2021CTECryosite Limited
09/09/2021CTECryosite Limited

Company Overview

Cryosite Limited is engaged in the supply chain logistics and management of pharmaceutical products used in clinical trials and biological materials in Australia. The Company operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The Company engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

CTE in the news

Biotech company Cryosite (CTE) has appointed John Hogg as its new company…

Search Previous Announcements